Shingles (Recombinant)
Shingles, or herpes zoster, is a painful condition caused by the reactivation of the chickenpox virus (varicella-zoster) in individuals who have previously had chickenpox. The recombinant shingles vaccine offers effective protection, especially for older adults and those with weakened immune systems.
Countries at Risk
Shingles is not region-specific but commonly affects individuals aged 50 and older. Travelers in this age group or those with weakened immune systems should consider vaccination before long-term trips.
Travel Precautions
To reduce the risk of shingles and its complications:
Get vaccinated if eligible.
Practice good hygiene and avoid sharing personal items.
Avoid contact with individuals with active chickenpox or shingles if you are immunocompromised.
Signs & Symptoms
Tingling, itching, or burning sensation on the skin
Painful rash with blisters, often on one side of the body
Fever, fatigue, and sensitivity to touch
Complications: Long-term nerve pain, bacterial infections, or vision problems if the rash is near the eyes
The Vaccination
Course: 2 doses.
When to Vaccinate: The first dose is given at any time, followed by a second dose 2 to 6 months later.
Duration of Protection: Provides long-term immunity, significantly reducing the risk of shingles and its complications.
Side Effects: Mild redness, swelling, or itching at the injection site, muscle pain, or fatigue.
Who Should Vaccinate: Individuals aged 50 and above or those with weakened immune systems due to conditions or treatments.
Pricing
Number of Doses: 2
Per Dose: £235.00
Full Course: £470.00